Re: Note Purchase AgreementJishanye, Inc. • June 17th, 2016 • Medicinal chemicals & botanical products • Delaware
The undersigned (the "Purchaser") hereby agrees to purchase the 8% convertible note due May 31, 2017 (the "Note") of Jishanye, Inc., a Nevada corporation (the "Company"), as are set forth on the signature page of this Agreement, at a purchase price per share (the "Purchase Price") equal to the principal amount of the Note being purchased. The Note shall be in substantially the form of Exhibit A to this Agreement. The Purchase Price (the "Purchase Price") for the Note is set forth on the signature page of this Agreement. The Note is being issued as part of a financing (the "Financing") pursuant to which the Company is selling Notes the maximum principal amount of $1,000,000, with no minimum amount required. The principal amount of the Note is convertible into of shares of the Company's common stock, par value $0.0001 per share ("Common Stock") at a conversion price (the "Conversion Price") of $3.33 per share. The shares of Common Stock issuable upon conversion of the Notes are referred
